NDC 63323-489-01 - XYLOCAINE-MPF WITH EPI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-489
- Requested NDC
- 63323-489-01
- Package NDCs from labels
- 63323-489-02, 63323-489-27, 63323-489-03, 63323-489-21, 63323-489-01, 63323-489-17
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2026-06-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| XYLOCAINE-MPF WITH EPI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-06-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Henry Schein, Inc. | Henry Schein, Inc. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| SODIUM CHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - A-S Medication Solutions | A-S Medication Solutions | 2019-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-489-01 | XylocaineMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-489-02 | XylocaineMPF | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-489-03 | XylocaineMPF | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-489-17 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-489-21 | XylocaineMPF | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 13 | |
| 63323-489-27 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-489 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-489-01 | ML - Milliliter | 63323-489 | 402305d2-a2ba-4b33-9fa8-ab46fcf60153 | 1 | 2020-04-20 |
| 63323-489-02 | ML - Milliliter | 63323-489 | df03fb66-fedf-4500-b351-a5ca5cb881c6 | 1 | 2020-01-03 |
| 63323-489-03 | ML - Milliliter | 63323-489 | 82287f5e-6d70-4e4e-b6f9-b8aed85aea88 | 1 | 2020-04-20 |
| 63323-489-17 | ML - Milliliter | 63323-489 | 060d2a30-ef0f-4217-b6a1-2b9480814a95 | 1 | 2012-07-24 |
| 63323-489-21 | ML - Milliliter | 63323-489 | 54ff07e7-5f48-4ea2-a418-1a939aa466c1 | 1 | 2012-07-24 |
| 63323-489-27 | ML - Milliliter | 63323-489 | 166479a5-291e-4225-b22f-086cf1193f69 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marbeta L Kit | BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | 9a6a3871-4e02-47f9-a20e-a256b3f3c498 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 1737566 |
| MLK F3 Kit | MARCAINE, LIDOCAINE, KENALOG, POVIDONE IODINE | Asclemed USA, Inc. | 481aeef5-01cb-4567-a67f-896e6929b2ed | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 1737757 |
| Dyural 80 Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, SODIUM CHLORIDE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | e9f7f923-e7f9-4c52-b56d-914d800c1acf | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 1737566 |
| Lidolog Kit | LIDOCAINE, KENALOG, POVIDONE IODINE | Asclemed USA, Inc. | 069e145d-7992-4f56-9fcb-20782ecc2d53 | 2026-01-08 | Warnings, Adverse reactions | 1737757 |
| Dyural L Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | 4879f990-e879-47e1-99bc-b4bfcb32bcff | 2026-01-08 | Warnings, Adverse reactions | 1737566 |
| Multi-Specialty Kit | DEPO-MEDROL, LIDOCAINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | 5f2768d1-90c4-4d73-902d-fc7a947da7a5 | 2026-01-08 | Warnings, Adverse reactions | 1737568 |
| Ketorocaine L Kit | KETOROLAC TROMETHAMINE, LIDOCAINE HYDROCHLORIDE, POVIDINE IODINE | Asclemed USA, Inc. | ee0d396c-5caa-4a1a-9865-1a742d9d8d68 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 1737568 |
| Dyural LM Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | cdd72141-10b6-48c6-85be-5b1294c8539c | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 1737566 |
| Anti-Constipation Drops 2077 | ANTI-CONSTIPATION DROPS | Professional Complementary Health Formulas | 55d105fe-5698-43a6-9252-eaa9b63299d0 | 2026-01-08 | Warnings | 451W47IQ8X |
| Anxious Drops 2098 | ANXIOUS DROPS | Professional Complementary Health Formulas | a5dc8619-074a-4c1f-8bb2-fea788f5aff1 | 2026-01-08 | Warnings | 451W47IQ8X |
| Spleen Thymus Liquescence 3023 | SPLEEN THYMUS LIQUESCENCE | Professional Complementary Health Formulas | abe3c5c4-c5b4-47dd-afe3-b7858c82f775 | 2026-01-08 | Warnings | 451W47IQ8X |
| RET Bladder 7006 | RET BLADDER | Professional Complementary Health Formulas | f1d354e7-3d72-40aa-aaf1-172cb39f0711 | 2026-01-08 | Warnings | 451W47IQ8X |
| Cataract Drops 2085 | CATARACT DROPS | Professional Complementary Health Formulas | 6040a096-ccdb-4e1e-a242-be29c3127f27 | 2026-01-08 | Warnings | 451W47IQ8X |
| Psorinum Miasm Drops 2054 | PSORINUM MIASM DROPS | Professional Complementary Health Formulas | a34aadab-b634-461f-a0ff-58f42f6e0833 | 2026-01-08 | Warnings | 451W47IQ8X |
| Opsin II 6015 | OPSIN II | Professional Complementary Health Formulas | 848d620e-ddd5-4787-a4bd-844be7615432 | 2026-01-08 | Warnings | 451W47IQ8X |
| Northwest Regional 1019 | NORTHWEST REGIONAL | Professional Complementary Health Formulas | 4dccc9f6-4d9e-4eec-b031-1fccdddb3d03 | 2026-01-08 | Warnings | 451W47IQ8X |
| Headache Drops 2027 | HEADACHE DROPS | Professional Complementary Health Formulas | a7e345fb-c4aa-4b10-8074-9d8c37304142 | 2026-01-08 | Warnings | 451W47IQ8X |
| Metab 6012 | METAB | Professional Complementary Health Formulas | f3576d6f-c9ab-4370-8a32-b6c4bf6ba4fd | 2026-01-08 | Warnings | 451W47IQ8X |
| Cell Salt Combination 8013 | CELL SALT COMBINATION | Professional Complementary Health Formulas | b3a33345-3c3d-4f86-ae4d-757c65fd1ed3 | 2026-01-08 | Warnings | 451W47IQ8X |
| Shingles Nosode 4028 | SHINGLES NOSODE | Professional Complementary Health Formulas | e71d917a-af9f-41e9-a3de-cb588db7e022 | 2026-01-08 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.